Keros Therapeutics Inc. (KROS) NASDAQ
$28.56 1.79 (6.69%)
Market Cap: $686.44M
As of 06/24/22 04:00 PM EDT. Market closed.

Keros Therapeutics Inc. (KROS) NASDAQ
$28.56 1.79 (6.69%)
Market Cap: $686.44M
As of 06/24/22 04:00 PM EDT. Market closed.
Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with high unmet medical need. Keros is a leader in understanding the role of the Transforming Growth Factor-Beta family of proteins, which are master regulators of red blood cell and platelet ... read more
Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with high unmet medical need. Keros is a leader in understanding the role of the Transforming Growth Factor-Beta family of proteins, which are master regulators of red blood cell and platelet production as well as of the growth, repair and maintenance of muscle and bone. Keros' lead protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes and in patients with myelofibrosis. Keros' lead small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from iron imbalance, as well as for the treatment of fibrodysplasia ossificans progressiva. Keros' third product candidate, KER-012, is being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Lachey Jennifer | Chief Scientific Officer | Jun 14, 2022 | Option Exercise | $0.30 | 9,400 | 2,820 | 95,100 | Jun 14, 2022, 06:57 PM |
Seehra Jasbir | Chief Executive Officer | Jun 09, 2022 | Option Exercise | $0.30 | 5,000 | 1,500 | 248,856 | Jun 10, 2022, 04:12 PM |
Lachey Jennifer | Chief Scientific Officer | May 11, 2022 | Option Exercise | $0.30 | 5,300 | 1,590 | 91,000 | May 13, 2022, 04:37 PM |
Lachey Jennifer | Chief Scientific Officer | May 11, 2022 | Sale | $41.90 | 5,300 | 222,050 | 87,602 | May 13, 2022, 04:37 PM |
Lachey Jennifer | Chief Scientific Officer | Apr 11, 2022 | Option Exercise | $0.30 | 5,300 | 1,590 | 91,000 | Apr 13, 2022, 04:36 PM |
Lachey Jennifer | Chief Scientific Officer | Apr 11, 2022 | Sale | $62.77 | 5,300 | 332,705 | 89,583 | Apr 13, 2022, 04:36 PM |
Rovaldi Christopher | Chief Operating Officer | Apr 06, 2022 | Option Exercise | $16.00 | 1,728 | 27,648 | 1,728 | Apr 08, 2022, 04:21 PM |
Rovaldi Christopher | Chief Operating Officer | Apr 06, 2022 | Sale | $65.00 | 1,728 | 112,320 | 0 | Apr 08, 2022, 04:21 PM |
Lachey Jennifer | Chief Scientific Officer | Apr 04, 2022 | Option Exercise | $0.30 | 7,950 | 2,385 | 93,650 | Apr 06, 2022, 04:49 PM |
Lachey Jennifer | Chief Scientific Officer | Apr 04, 2022 | Sale | $60.00 | 7,950 | 477,000 | 85,700 | Apr 06, 2022, 04:49 PM |
Rovaldi Christopher | Chief Operating Officer | Apr 01, 2022 | Option Exercise | $16.00 | 864 | 13,824 | 864 | Apr 05, 2022, 04:31 PM |
Rovaldi Christopher | Chief Operating Officer | Apr 01, 2022 | Sale | $57.49 | 864 | 49,675 | 862 | Apr 05, 2022, 04:31 PM |
Lachey Jennifer | Chief Scientific Officer | Mar 11, 2022 | Option Exercise | $0.30 | 2,650 | 795 | 88,350 | Mar 15, 2022, 04:37 PM |
Lachey Jennifer | Chief Scientific Officer | Mar 11, 2022 | Sale | $53.38 | 2,650 | 141,449 | 87,288 | Mar 15, 2022, 04:37 PM |
Lachey Jennifer | Chief Scientific Officer | Feb 11, 2022 | Option Exercise | $0.30 | 2,650 | 795 | 88,350 | Feb 15, 2022, 04:26 PM |
Lachey Jennifer | Chief Scientific Officer | Feb 11, 2022 | Sale | $52.06 | 2,650 | 137,965 | 87,277 | Feb 15, 2022, 04:26 PM |
Lachey Jennifer | Chief Scientific Officer | Jan 11, 2022 | Option Exercise | $0.30 | 2,650 | 795 | 88,350 | Jan 13, 2022, 04:39 PM |
Lachey Jennifer | Chief Scientific Officer | Jan 11, 2022 | Sale | $53.75 | 2,650 | 142,447 | 88,030 | Jan 13, 2022, 04:39 PM |
Lachey Jennifer | Chief Scientific Officer | Jan 05, 2022 | Option Exercise | $0.30 | 2,650 | 795 | 88,350 | Jan 07, 2022, 04:35 PM |
Lachey Jennifer | Chief Scientific Officer | Jan 05, 2022 | Sale | $60.00 | 2,650 | 159,000 | 85,700 | Jan 07, 2022, 04:35 PM |
Knowles Julius | Director | Jan 05, 2022 | Sale | $58.25 | 4,034 | 234,991 | 343,597 | Jan 05, 2022, 07:14 PM |
Knowles Julius | Director | Jan 04, 2022 | Sale | $57.55 | 20,062 | 1,154,667 | 355,365 | Jan 05, 2022, 07:14 PM |
Knowles Julius | Director | Jan 03, 2022 | Sale | $58.01 | 23,555 | 1,366,458 | 366,738 | Jan 05, 2022, 07:14 PM |
Lachey Jennifer | Chief Scientific Officer | Dec 15, 2021 | Option Exercise | $0.30 | 735 | 221 | 86,435 | Dec 15, 2021, 04:48 PM |
Lachey Jennifer | Chief Scientific Officer | Dec 13, 2021 | Option Exercise | $0.30 | 1,915 | 575 | 87,615 | Dec 15, 2021, 04:48 PM |
Lachey Jennifer | Chief Scientific Officer | Dec 13, 2021 | Sale | $50.55 | 1,915 | 96,808 | 86,097 | Dec 15, 2021, 04:48 PM |
Lachey Jennifer | Chief Scientific Officer | Dec 15, 2021 | Sale | $50.00 | 735 | 36,750 | 85,700 | Dec 15, 2021, 04:48 PM |
Knowles Julius | Director | Dec 02, 2021 | Sale | $53.57 | 25,338 | 1,357,381 | 385,673 | Dec 03, 2021, 05:05 PM |
Knowles Julius | Director | Dec 01, 2021 | Sale | $54.68 | 22,313 | 1,219,994 | 395,014 | Dec 03, 2021, 05:05 PM |
Lachey Jennifer | Chief Scientific Officer | Nov 11, 2021 | Option Exercise | $0.30 | 5,300 | 1,590 | 91,000 | Nov 12, 2021, 04:40 PM |
Lachey Jennifer | Chief Scientific Officer | Nov 10, 2021 | Option Exercise | $0.30 | 15,900 | 4,770 | 101,600 | Nov 12, 2021, 04:40 PM |
Lachey Jennifer | Chief Scientific Officer | Nov 11, 2021 | Sale | $59.63 | 5,300 | 316,058 | 90,261 | Nov 12, 2021, 04:40 PM |
Lachey Jennifer | Chief Scientific Officer | Nov 10, 2021 | Sale | $60.00 | 15,900 | 954,000 | 85,700 | Nov 12, 2021, 04:40 PM |
Lachey Jennifer | Chief Scientific Officer | Nov 04, 2021 | Option Exercise | $0.30 | 10,600 | 3,180 | 96,300 | Nov 05, 2021, 05:06 PM |
Lachey Jennifer | Chief Scientific Officer | Nov 04, 2021 | Sale | $50.00 | 10,600 | 530,000 | 85,700 | Nov 05, 2021, 05:06 PM |
Knowles Julius | Director | Nov 03, 2021 | Sale | $41.95 | 15,967 | 669,780 | 402,854 | Nov 03, 2021, 07:04 PM |
Knowles Julius | Director | Nov 02, 2021 | Sale | $42.40 | 7,881 | 334,149 | 410,439 | Nov 03, 2021, 07:04 PM |
Knowles Julius | Director | Nov 01, 2021 | Sale | $42.15 | 23,803 | 1,003,201 | 421,041 | Nov 03, 2021, 07:04 PM |
Knowles Julius | Director | Oct 20, 2021 | Sale | $38.24 | 4,082 | 156,095 | 430,340 | Oct 21, 2021, 04:29 PM |
Knowles Julius | Director | Oct 19, 2021 | Sale | $38.16 | 4,516 | 172,346 | 431,273 | Oct 21, 2021, 04:29 PM |
Knowles Julius | Director | Oct 18, 2021 | Sale | $37.70 | 13,786 | 519,711 | 433,394 | Oct 18, 2021, 08:35 PM |
Knowles Julius | Director | Oct 15, 2021 | Sale | $39.16 | 8,198 | 321,052 | 443,577 | Oct 18, 2021, 08:35 PM |
Knowles Julius | Director | Oct 14, 2021 | Sale | $40.13 | 4,383 | 175,890 | 446,608 | Oct 18, 2021, 08:35 PM |
Knowles Julius | Director | Oct 01, 2021 | Sale | $40.16 | 6,323 | 253,932 | 453,112 | Oct 05, 2021, 08:47 PM |
Knowles Julius | Director | Oct 05, 2021 | Sale | $40.03 | 2,617 | 104,759 | 449,261 | Oct 05, 2021, 08:47 PM |
Knowles Julius | Director | Oct 04, 2021 | Sale | $40.06 | 3,746 | 150,065 | 450,845 | Oct 05, 2021, 08:47 PM |
Knowles Julius | Director | Sep 27, 2021 | Sale | $41.17 | 95,302 | 3,924,003 | 487,249 | Sep 29, 2021, 04:39 PM |
Lachey Jennifer | Chief Scientific Officer | Aug 17, 2021 | Option Exercise | $0.30 | 1,293 | 388 | 85,700 | Aug 18, 2021, 05:21 PM |
Knowles Julius | Director | Jul 02, 2021 | Sale | $41.34 | 23,818 | 984,565 | 520,411 | Jul 06, 2021, 06:02 PM |
Knowles Julius | Director | Jul 01, 2021 | Sale | $41.28 | 23,834 | 983,787 | 530,196 | Jul 06, 2021, 06:02 PM |
Lachey Jennifer | Chief Scientific Officer | Jun 24, 2021 | Option Exercise | $0.30 | 6,500 | 1,950 | 84,407 | Jun 25, 2021, 06:29 PM |
Knowles Julius | Director | Jun 03, 2021 | Sale | $47.97 | 7,895 | 378,730 | 558,132 | Jun 03, 2021, 08:06 PM |
Knowles Julius | Director | Jun 02, 2021 | Sale | $48.76 | 11,529 | 562,138 | 562,028 | Jun 03, 2021, 08:06 PM |
Knowles Julius | Director | Jun 01, 2021 | Sale | $52.51 | 8,812 | 462,686 | 569,996 | Jun 03, 2021, 08:06 PM |
Ordonez Claudia | Chief Medical Officer | May 11, 2021 | Option Exercise | $0.48 | 1,000 | 480 | 1,000 | May 13, 2021, 04:37 PM |
Ordonez Claudia | Chief Medical Officer | May 11, 2021 | Sale | $50.15 | 1,000 | 50,150 | 0 | May 13, 2021, 04:37 PM |
Lachey Jennifer | Chief Scientific Officer | May 13, 2021 | Option Exercise | $0.12 | 6,720 | 834 | 77,907 | May 13, 2021, 04:36 PM |
Lachey Jennifer | Chief Scientific Officer | May 11, 2021 | Option Exercise | $0.30 | 2,650 | 795 | 73,837 | May 13, 2021, 04:36 PM |
Lachey Jennifer | Chief Scientific Officer | May 11, 2021 | Sale | $50.00 | 2,650 | 132,500 | 71,187 | May 13, 2021, 04:36 PM |
Ordonez Claudia | Chief Medical Officer | Apr 12, 2021 | Option Exercise | $0.48 | 1,000 | 480 | 1,000 | Apr 14, 2021, 04:46 PM |
Ordonez Claudia | Chief Medical Officer | Apr 12, 2021 | Sale | $59.93 | 1,000 | 59,926 | 600 | Apr 14, 2021, 04:46 PM |
Lachey Jennifer | Chief Scientific Officer | Apr 12, 2021 | Option Exercise | $0.30 | 5,300 | 1,590 | 76,487 | Apr 14, 2021, 04:43 PM |
Lachey Jennifer | Chief Scientific Officer | Apr 12, 2021 | Sale | $60.00 | 5,300 | 318,026 | 75,489 | Apr 14, 2021, 04:43 PM |
Knowles Julius | Director | Apr 05, 2021 | Sale | $60.07 | 27,151 | 1,630,832 | 622,909 | Apr 05, 2021, 09:11 PM |
Knowles Julius | Director | Apr 01, 2021 | Sale | $58.89 | 11,202 | 659,704 | 626,197 | Apr 05, 2021, 09:11 PM |
Lachey Jennifer | Chief Scientific Officer | Apr 01, 2021 | Option Exercise | $0.11 | 9,996 | 1,100 | 71,187 | Apr 02, 2021, 04:32 PM |
Ordonez Claudia | Chief Medical Officer | Mar 11, 2021 | Option Exercise | $0.48 | 1,000 | 480 | 1,000 | Mar 15, 2021, 04:45 PM |
Ordonez Claudia | Chief Medical Officer | Mar 11, 2021 | Sale | $64.56 | 1,000 | 64,556 | 605 | Mar 15, 2021, 04:45 PM |
Lachey Jennifer | Chief Scientific Officer | Mar 11, 2021 | Option Exercise | $0.30 | 5,300 | 1,590 | 66,491 | Mar 15, 2021, 04:43 PM |
Lachey Jennifer | Chief Scientific Officer | Mar 11, 2021 | Sale | $64.48 | 5,300 | 341,750 | 64,752 | Mar 15, 2021, 04:43 PM |
Knowles Julius | Director | Mar 04, 2021 | Sale | $55.48 | 11,632 | 645,385 | 635,365 | Mar 05, 2021, 07:44 PM |
Knowles Julius | Director | Mar 03, 2021 | Sale | $57.36 | 12,327 | 707,115 | 643,695 | Mar 05, 2021, 07:44 PM |
Knowles Julius | Director | Mar 02, 2021 | Sale | $58.75 | 10,711 | 629,285 | 647,327 | Mar 03, 2021, 08:40 PM |
Knowles Julius | Director | Mar 01, 2021 | Sale | $63.09 | 12,979 | 818,793 | 657,219 | Mar 03, 2021, 08:40 PM |
Lachey Jennifer | Chief Scientific Officer | Feb 26, 2021 | Option Exercise | $0.11 | 33,200 | 3,652 | 61,191 | Mar 01, 2021, 04:54 PM |
Knowles Julius | Director | Feb 16, 2021 | Sale | $59.89 | 9,612 | 575,671 | 675,481 | Feb 18, 2021, 06:46 PM |
Knowles Julius | Director | Feb 18, 2021 | Sale | $63.11 | 2,944 | 185,785 | 660,379 | Feb 18, 2021, 06:46 PM |
Knowles Julius | Director | Feb 17, 2021 | Sale | $61.05 | 16,061 | 980,588 | 669,685 | Feb 18, 2021, 06:46 PM |
Knowles Julius | Director | Feb 12, 2021 | Sale | $61.53 | 7,468 | 459,495 | 679,390 | Feb 16, 2021, 05:50 PM |
Knowles Julius | Director | Feb 11, 2021 | Sale | $64.82 | 11,561 | 749,441 | 687,251 | Feb 16, 2021, 05:50 PM |
Ordonez Claudia | Chief Medical Officer | Feb 11, 2021 | Option Exercise | $0.48 | 1,000 | 480 | 1,000 | Feb 16, 2021, 05:49 PM |
Ordonez Claudia | Chief Medical Officer | Feb 11, 2021 | Sale | $64.84 | 1,000 | 64,841 | 825 | Feb 16, 2021, 05:49 PM |
Lachey Jennifer | Chief Scientific Officer | Feb 11, 2021 | Option Exercise | $0.30 | 5,300 | 1,590 | 33,291 | Feb 16, 2021, 05:47 PM |
Lachey Jennifer | Chief Scientific Officer | Feb 11, 2021 | Sale | $64.91 | 5,300 | 344,017 | 32,844 | Feb 16, 2021, 05:47 PM |
Nussbaum Ran | Director | Nov 17, 2020 | Buy | $50.00 | 60,000 | 3,000,000 | 2,288,151 | Nov 19, 2020, 04:40 PM |
Kariv Tomer | Director | Nov 17, 2020 | Buy | $50.00 | 60,000 | 3,000,000 | 2,288,151 | Nov 19, 2020, 04:39 PM |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Nov 17, 2020 | Buy | $50.00 | 60,000 | 3,000,000 | 2,288,151 | Nov 19, 2020, 04:38 PM |
Arkin Bio Ventures Limited Partnership | 10% Owner | Apr 13, 2020 | Buy | $16.00 | 120,000 | 1,920,000 | 2,013,102 | Apr 13, 2020, 05:29 PM |
Seehra Jasbir | Chief Executive Officer | Apr 13, 2020 | Buy | $16.00 | 20,000 | 320,000 | 243,856 | Apr 13, 2020, 05:19 PM |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Apr 13, 2020 | Buy | $16.00 | 437,499 | 6,999,984 | 2,261,517 | Apr 13, 2020, 05:18 PM |
ORBIMED ADVISORS LLC | Director | Apr 13, 2020 | Buy | $16.00 | 375,200 | 6,003,200 | 1,119,812 | Apr 13, 2020, 05:17 PM |
Nussbaum Ran | Director | Apr 13, 2020 | Buy | $16.00 | 437,499 | 6,999,984 | 2,261,517 | Apr 13, 2020, 05:16 PM |
Lazarus Alon | Director | Apr 13, 2020 | Buy | $16.00 | 120,000 | 1,920,000 | 2,013,102 | Apr 13, 2020, 05:15 PM |
Kariv Tomer | Director | Apr 13, 2020 | Buy | $16.00 | 437,499 | 6,999,984 | 2,261,517 | Apr 13, 2020, 05:13 PM |
GORDON CARL L | Director | Apr 13, 2020 | Buy | $16.00 | 375,200 | 6,003,200 | 1,119,812 | Apr 13, 2020, 05:12 PM |
Owner | Relationship | Date | Value($) |
Lachey Jennifer | Chief Scientific Officer | 06/14/2022 | 2,820 |
Seehra Jasbir | Chief Executive Officer | 06/09/2022 | 1,500 |
Lachey Jennifer | Chief Scientific Officer | 05/11/2022 | 1,590 |
Lachey Jennifer | Chief Scientific Officer | 05/11/2022 | 222,050 |
Lachey Jennifer | Chief Scientific Officer | 04/11/2022 | 1,590 |
Lachey Jennifer | Chief Scientific Officer | 04/11/2022 | 332,705 |
Rovaldi Christopher | Chief Operating Officer | 04/06/2022 | 27,648 |
Rovaldi Christopher | Chief Operating Officer | 04/06/2022 | 112,320 |
Lachey Jennifer | Chief Scientific Officer | 04/04/2022 | 2,385 |
Lachey Jennifer | Chief Scientific Officer | 04/04/2022 | 477,000 |
Rovaldi Christopher | Chief Operating Officer | 04/01/2022 | 13,824 |
Rovaldi Christopher | Chief Operating Officer | 04/01/2022 | 49,675 |
Lachey Jennifer | Chief Scientific Officer | 03/11/2022 | 795 |
Lachey Jennifer | Chief Scientific Officer | 03/11/2022 | 141,449 |
Lachey Jennifer | Chief Scientific Officer | 02/11/2022 | 795 |
Lachey Jennifer | Chief Scientific Officer | 02/11/2022 | 137,965 |
Lachey Jennifer | Chief Scientific Officer | 01/11/2022 | 795 |
Lachey Jennifer | Chief Scientific Officer | 01/11/2022 | 142,447 |
Lachey Jennifer | Chief Scientific Officer | 01/05/2022 | 795 |
Lachey Jennifer | Chief Scientific Officer | 01/05/2022 | 159,000 |
Knowles Julius | Director | 01/05/2022 | 234,991 |
Knowles Julius | Director | 01/04/2022 | 1,154,667 |
Knowles Julius | Director | 01/03/2022 | 1,366,458 |
Lachey Jennifer | Chief Scientific Officer | 12/15/2021 | 221 |
Lachey Jennifer | Chief Scientific Officer | 12/13/2021 | 575 |
Lachey Jennifer | Chief Scientific Officer | 12/13/2021 | 96,808 |
Lachey Jennifer | Chief Scientific Officer | 12/15/2021 | 36,750 |
Knowles Julius | Director | 12/02/2021 | 1,357,381 |
Knowles Julius | Director | 12/01/2021 | 1,219,994 |
Lachey Jennifer | Chief Scientific Officer | 11/11/2021 | 1,590 |
Lachey Jennifer | Chief Scientific Officer | 11/10/2021 | 4,770 |
Lachey Jennifer | Chief Scientific Officer | 11/11/2021 | 316,058 |
Lachey Jennifer | Chief Scientific Officer | 11/10/2021 | 954,000 |
Lachey Jennifer | Chief Scientific Officer | 11/04/2021 | 3,180 |
Lachey Jennifer | Chief Scientific Officer | 11/04/2021 | 530,000 |
Knowles Julius | Director | 11/03/2021 | 669,780 |
Knowles Julius | Director | 11/02/2021 | 334,149 |
Knowles Julius | Director | 11/01/2021 | 1,003,201 |
Knowles Julius | Director | 10/20/2021 | 156,095 |
Knowles Julius | Director | 10/19/2021 | 172,346 |
Knowles Julius | Director | 10/18/2021 | 519,711 |
Knowles Julius | Director | 10/15/2021 | 321,052 |
Knowles Julius | Director | 10/14/2021 | 175,890 |
Knowles Julius | Director | 10/01/2021 | 253,932 |
Knowles Julius | Director | 10/05/2021 | 104,759 |
Knowles Julius | Director | 10/04/2021 | 150,065 |
Knowles Julius | Director | 09/27/2021 | 3,924,003 |
Lachey Jennifer | Chief Scientific Officer | 08/17/2021 | 388 |
Knowles Julius | Director | 07/02/2021 | 984,565 |
Knowles Julius | Director | 07/01/2021 | 983,787 |
Lachey Jennifer | Chief Scientific Officer | 06/24/2021 | 1,950 |
Knowles Julius | Director | 06/03/2021 | 378,730 |
Knowles Julius | Director | 06/02/2021 | 562,138 |
Knowles Julius | Director | 06/01/2021 | 462,686 |
Ordonez Claudia | Chief Medical Officer | 05/11/2021 | 480 |
Ordonez Claudia | Chief Medical Officer | 05/11/2021 | 50,150 |
Lachey Jennifer | Chief Scientific Officer | 05/13/2021 | 834 |
Lachey Jennifer | Chief Scientific Officer | 05/11/2021 | 795 |
Lachey Jennifer | Chief Scientific Officer | 05/11/2021 | 132,500 |
Ordonez Claudia | Chief Medical Officer | 04/12/2021 | 480 |
Ordonez Claudia | Chief Medical Officer | 04/12/2021 | 59,926 |
Lachey Jennifer | Chief Scientific Officer | 04/12/2021 | 1,590 |
Lachey Jennifer | Chief Scientific Officer | 04/12/2021 | 318,026 |
Knowles Julius | Director | 04/05/2021 | 1,630,832 |
Knowles Julius | Director | 04/01/2021 | 659,704 |
Lachey Jennifer | Chief Scientific Officer | 04/01/2021 | 1,100 |
Ordonez Claudia | Chief Medical Officer | 03/11/2021 | 480 |
Ordonez Claudia | Chief Medical Officer | 03/11/2021 | 64,556 |
Lachey Jennifer | Chief Scientific Officer | 03/11/2021 | 1,590 |
Lachey Jennifer | Chief Scientific Officer | 03/11/2021 | 341,750 |
Knowles Julius | Director | 03/04/2021 | 645,385 |
Knowles Julius | Director | 03/03/2021 | 707,115 |
Knowles Julius | Director | 03/02/2021 | 629,285 |
Knowles Julius | Director | 03/01/2021 | 818,793 |
Lachey Jennifer | Chief Scientific Officer | 02/26/2021 | 3,652 |
Knowles Julius | Director | 02/16/2021 | 575,671 |
Knowles Julius | Director | 02/18/2021 | 185,785 |
Knowles Julius | Director | 02/17/2021 | 980,588 |
Knowles Julius | Director | 02/12/2021 | 459,495 |
Knowles Julius | Director | 02/11/2021 | 749,441 |
Ordonez Claudia | Chief Medical Officer | 02/11/2021 | 480 |
Ordonez Claudia | Chief Medical Officer | 02/11/2021 | 64,841 |
Lachey Jennifer | Chief Scientific Officer | 02/11/2021 | 1,590 |
Lachey Jennifer | Chief Scientific Officer | 02/11/2021 | 344,017 |
Nussbaum Ran | Director | 11/17/2020 | 3,000,000 |
Kariv Tomer | Director | 11/17/2020 | 3,000,000 |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 11/17/2020 | 3,000,000 |
Arkin Bio Ventures Limited Partnership | 10% Owner | 04/13/2020 | 1,920,000 |
Seehra Jasbir | Chief Executive Officer | 04/13/2020 | 320,000 |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 04/13/2020 | 6,999,984 |
ORBIMED ADVISORS LLC | Director | 04/13/2020 | 6,003,200 |
Nussbaum Ran | Director | 04/13/2020 | 6,999,984 |
Lazarus Alon | Director | 04/13/2020 | 1,920,000 |
Kariv Tomer | Director | 04/13/2020 | 6,999,984 |
GORDON CARL L | Director | 04/13/2020 | 6,003,200 |
Period of Report: 03/31/2022
10-K/10-Q Filings: View